Hyro secures $15M Series B extension to tackle healthcare’s AI needs
Over the past year, the company has doubled its annual recurring revenue and expanded its client base and partnerships with platforms like Salesforce and Cisco.
Healthcare AI startup Hyro has raised an additional $15 million in a Series B extension, bringing its total funding to $50 million. The extension, led by Healthier Capital, adds to the $20 million Hyro secured in its initial Series B round announced in May 2023. Notable investors in the company include Macquarie Capital, Liberty Mutual, Twilio, and Black Opal Ventures.
Full list of Israeli high-tech funding rounds in 2024
The funding comes as Hyro tackles the rising demand for AI-driven communication solutions in the healthcare sector. Its platform uses a blend of large language models (LLMs) and proprietary natural language processing technologies to streamline patient interactions across call centers, web portals, and mobile apps. According to the company, Hyro’s AI agents resolve up to 85% of routine queries, such as appointment scheduling and prescription refills, reducing operational costs by 35% for health systems.
Founded in 2018 by Israel Krush and Rom Cohen, Hyro serves major U.S. health systems, including Intermountain Health, Emory Healthcare, and Texas Health Resources. Over the past year, the company has doubled its annual recurring revenue and expanded its client base and partnerships with platforms like Salesforce and Cisco.
Related articles:
The new capital will help Hyro refine its platform, including outbound calling features to reduce appointment no-shows and enhanced analytics to provide actionable insights. By addressing the dual pressures of rising patient expectations and healthcare resource constraints, Hyro aims to further entrench itself as a leader in responsible AI-powered healthcare communications.
